Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

We've all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could ...

Chronic obstructive pulmonary disease (COPD) and other lower respiratory diseases are among leading causes of U.S. deaths per ...

The global patient monitoring market size was valued at USD 55.60 billion in 2024 and is projected to reach from USD 59.66 billion in 2025 to USD 112.47 billion by 2033, growing at a CAGR of 7.3% ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...

Walking, or atypical, pneumonia, is a mild form of pneumonia that often resembles a cold. You may not have a high fever and ...

Aerobic exercise and a bath are part of columnist Caroline Gainer's evening routine, which helps her manage COPD and get ...

There is a misconception that experiencing constant breathlessness is a typical part of getting older when this is not the ...